Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiri Petera

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|March 13, 2019
Validation of dose distribution computation on sCT images generated from MRI scans by Philips MRCATIva Bratova, Petr Paluska, Jakub Grepl, et al.
Hepato-Gastroenterology|September 19, 2009
Expression of p53, p21 and p16 does not correlate with response to preoperative chemoradiation in gastric carcinomaIgor Sirak, Jiri Petera, Jana Hatlova, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|December 31, 2013
Hyperfractionated high-dose rate brachytherapy in the treatment of oral tongue cancerLubos Tuček, Jiri Petera, Igor Sirák, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|February 5, 2021
Controversies of radiotherapy in human epidermal growth factor receptor (HER)-2 positive breast cancer patientsIveta Kolarova, Bohuslav Melichar, Jaroslav Vanasek, et al.
Oncology Reports|September 6, 2005
Is it reasonable to consider second-line chemotherapy in patients with hormone-refractory prostate cancer?Karel Odrazka, Miloslava Vaculikova, Martin Dolezel, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 19, 2008
Epidermal growth factor receptor as a predictor of tumor response to preoperative chemoradiation in locally advanced gastric carcinomaIgor Sirak, Jiri Petera, Jana Hatlova, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 26, 2003
Bi-weekly epirubicin, etoposide and low-dose dexamethasone for hormone-refractory prostate cancerKarel Odrazka, Miloslava Vaculikova, Jiri Petera, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|December 31, 2013
Utilization of cone-beam CT for offline evaluation of target volume coverage during prostate image-guided radiotherapy based on bony anatomy alignmentPetr Paluska, Josef Hanus, Jana Sefrova, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|August 15, 2024
Cardiac doses with deep inspiration breath hold in breast cancer radiotherapy: direct comparison between WBI, PBI, and interstitial APBIIgor Sirak, Denisa Pohanková, Linda Kašaová, et al.
Pathology Oncology Research : POR|August 6, 2013
Prognostic significance of human papillomavirus (HPV) status and expression of selected markers (HER2/neu, EGFR, VEGF, CD34, p63, p53 and Ki67/MIB-1) on outcome after (chemo-) radiotherapy in patients with squamous cell carcinoma of uterine cervixMilan Vosmik, Jan Laco, Igor Sirak, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|March 13, 2019
Validation of dose distribution computation on sCT images generated from MRI scans by Philips MRCATIva Bratova, Petr Paluska, Jakub Grepl, et al.
Hepato-Gastroenterology|September 19, 2009
Expression of p53, p21 and p16 does not correlate with response to preoperative chemoradiation in gastric carcinomaIgor Sirak, Jiri Petera, Jana Hatlova, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|December 31, 2013
Hyperfractionated high-dose rate brachytherapy in the treatment of oral tongue cancerLubos Tuček, Jiri Petera, Igor Sirák, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|February 5, 2021
Controversies of radiotherapy in human epidermal growth factor receptor (HER)-2 positive breast cancer patientsIveta Kolarova, Bohuslav Melichar, Jaroslav Vanasek, et al.
Oncology Reports|September 6, 2005
Is it reasonable to consider second-line chemotherapy in patients with hormone-refractory prostate cancer?Karel Odrazka, Miloslava Vaculikova, Martin Dolezel, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 19, 2008
Epidermal growth factor receptor as a predictor of tumor response to preoperative chemoradiation in locally advanced gastric carcinomaIgor Sirak, Jiri Petera, Jana Hatlova, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 26, 2003
Bi-weekly epirubicin, etoposide and low-dose dexamethasone for hormone-refractory prostate cancerKarel Odrazka, Miloslava Vaculikova, Jiri Petera, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|December 31, 2013
Utilization of cone-beam CT for offline evaluation of target volume coverage during prostate image-guided radiotherapy based on bony anatomy alignmentPetr Paluska, Josef Hanus, Jana Sefrova, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|August 15, 2024
Cardiac doses with deep inspiration breath hold in breast cancer radiotherapy: direct comparison between WBI, PBI, and interstitial APBIIgor Sirak, Denisa Pohanková, Linda Kašaová, et al.
Pathology Oncology Research : POR|August 6, 2013
Prognostic significance of human papillomavirus (HPV) status and expression of selected markers (HER2/neu, EGFR, VEGF, CD34, p63, p53 and Ki67/MIB-1) on outcome after (chemo-) radiotherapy in patients with squamous cell carcinoma of uterine cervixMilan Vosmik, Jan Laco, Igor Sirak, et al.
Pageof 4